Age-related macular degeneration has a high prevalence in industrialized societies and is the most common cause for loss of reading vision among patients older then 55 years of age (Martin et al. in Ophthalmology 119:1388–1398, 2012; Congdon et al. in Arch Ophthalmol 122:477–485, 2004). In recent years major advances have been made in the therapy of the neovascular form of age-related macular degeneration (Martin et al. in Ophthalmology 119:1388–1398, 2012; Rosenfeld et al. in N Engl J Med 355:1419–1431, 2006; Heier et al. in Ophthalmology 119:2537–2548, 2012), but reduced near visual acuity is still a major problem for all forms of age-related macular degeneration. External magnifying low visual aids are known for decades, but uncomfortable use and stigmatization in public limited their acceptance. They might affect the visual field and cannot be worn continuously. Furthermore they might be forgotten at home, lost or damaged.